Assignee
CIRIUS THERAPEUTICS INC
US·1 granted patent·5 pending applications·1 citations·filing 2019–2024
Top patents by PatentIndex Score
6 records- 0175US11931345B2Thiazolidinedione analogs for the treatment of NAFLD and metabolic diseasesCIRIUS THERAPEUTICS INC·Filed 2019·Granted Mar 19, 2024·1 cites·26 claims
- 0267US2024197689A1Thiazolidinedione analogs for the treatment of nafld and metabolic diseasesCIRIUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0362US2024216344A1Thiazolidinedione analogs for the treatment of nafld and metabolic diseasesCIRIUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0456US2023013627A1Thiazolidinedione analogs for the treatment of nafld and metabolic diseasesCIRIUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0552US2023210825A1Methods and compositions for treating subjects with metabolic disorders and coronavirus infectionsCIRIUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0646US2022031667A1Thiazolidinedione analogs for the treatment of nafld and metabolic diseasesCIRIUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →